Product Information
DICLOFENAC EPOLAMINE 1.3% PTCH is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $4.9562 per EA under NDC 00093372755. Its NADAC has been published 315 times since Jun 17, 2020.
Strength
.013 g/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093372755
Classification
Generic
Dosage Form
SYSTEM
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
DICLOFENAC EPOLAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021234On Market Since
5/1/2020
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC EPOLAMINE 1.3% PTCH has been published 315 times since Jun 17, 2020, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9562 per EA |
|---|---|
| All-time high | $7.1487 (Mar 10, 2021) |
| All-time low | $4.3538 (Feb 19, 2025) |
| 52-week high | $5.0729 |
| 52-week low | $4.4049 |
| Median price | $5.6414 |
| Average price | $5.5527 |
| Largest weekly change | +21.0% (Aug 21, 2024) |
| Weeks tracked | 315 |
| Tracking since | Jun 17, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DICLOFENAC EPOLAMINE 1.3% PTCH?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC EPOLAMINE 1.3% PTCH, manufactured by Teva Pharmaceuticals USA Inc., is $4.9562 per EA (NDC 00093372755), effective Jun 24, 2026.
How has the price of DICLOFENAC EPOLAMINE 1.3% PTCH changed over time?
Over the history we have for it, the NADAC for DICLOFENAC EPOLAMINE 1.3% PTCH has declined 21.1%. It has been tracked across 315 weekly CMS publications since Jun 17, 2020.
What are the highest and lowest recorded NADAC prices for DICLOFENAC EPOLAMINE 1.3% PTCH?
Since Jun 17, 2020, the NADAC for DICLOFENAC EPOLAMINE 1.3% PTCH has ranged from a low of $4.3538 (Feb 19, 2025) to a high of $7.1487 (Mar 10, 2021), with a median of $5.6414 per EA.
Are there cheaper alternatives to DICLOFENAC EPOLAMINE 1.3% PTCH?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DICLOFENAC EPOLAMINE 1.3% PTCH, but none are currently priced below it.
Who manufactures DICLOFENAC EPOLAMINE 1.3% PTCH?
DICLOFENAC EPOLAMINE 1.3% PTCH (NDC 00093372755) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification